1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Emergency Contraception in France

Emergency Contraception in France

  • June 2013
  • -
  • Euromonitor International
  • -
  • 29 pages

The contraceptive model in France drastically changed in recent years, with the advent of new hormonal methods of contraception, such contraceptive implants, contraceptive skin patches and vaginal rings. Even though the pill remains the most widely used method (at 44% in 2012), the rapid adoption of Rx-mandatory contraceptive implants/patches and a higher tendency for the male partner to use condoms (due to growing awareness of the need to protect against STDs) curbed the demand for emergency...

Euromonitor International's Emergency Contraception in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?

* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Emergency Contraception in France
EMERGENCY CONTRACEPTION IN FRANCE
Euromonitor International
June 2013


LIST OF CONTENTS AND TABLES


Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2007-2012
Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
Table 3 Emergency Contraception Company Shares by Value 2008-2012
Table 4 Emergency Contraception Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Biogaran, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
Summary 1 Laboratoires Biogaran: Key Facts
Summary 2 Laboratoires Biogaran: Operational Indicators*
Company Background
Production
Competitive Positioning
Summary 3 Laboratoires Biogaran: Competitive Position 2012
Executive Summary
De-reimbursement Keeps Growing in France
France Welcomes the Approved List of Health and Nutrition Claims
Ameli Pushes for More Generics
Growing Competition Between Pharmacists and Other Distribution Channels
Moderate Growth Is Expected in the Forecast Period
Key Trends and Developments
the French Government Continues Its De-reimbursement Policy Because of Mounting Economic Problems in the Country
EU Adopts Vitamins and Dietary Supplements Approved List of Health and Nutrition Claims: Roadmap for Harmonisation in France
French Bodies Push for More Generic Drugs
Chemists/pharmacies Is Still the Most Frequented Channel for Consumer Health, But Faces Growing Competition
A Lethargic Socio-culture Impedes the Development of Self-medication
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Advertising
Vitamins and Dietary Supplements Registration and Classification
Distribution Channels
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC: Switches 2011-2012
Definitions
Sources
Summary 5 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.